ArticleInvestigative ophthalmology & visual science2025
Disruption of Epidermal Growth Factor Receptor Signaling in RPE Cells Increases Resistance to Ocular Toxoplasmosis.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose: The in vivo role of RPE cells in ocular toxoplasmosis is poorly understood. Toxoplasma gondii activates Epidermal growth factor receptor (EGFR) to avoid autophagic killing. We examined the in vivo role of RPE using mice with dominant negative (DN) EGFR in RPE. We examined whether EGFR blockade in RPE increased resistance to ocular toxoplasmosis, induced autophagy-dependent killing of T. gondii, and modulated retinal invasion by T. gondii. Methods: We bred mice expressing tetracycline-repressible transactivator under the control of MART-1 (RPE promotor) with mice expressing the tetracycline operator upstream of DN EGFR. Mice were infected with T. gondii tissue cysts. Histopathology and T. gondii B1 gene expression (qPCR) were examined. Retinal invasion by T. gondii was examined after intravenous challenge with the parasite. RPE were infected with T. gondii tachyzoites followed by assessment of parasite load and expression of LC3 and LAMP-1 (immunofluorescence). Results: Mice with DN EGFR in RPE exhibited lower parasite load and histopathology that became evident at 4 weeks post infection. No difference in parasite load was noted during hematogenous invasion of the retina by T. gondii. RPE with DN EGFR exhibited spontaneous recruitment of LC3 and LAMP-1 around intracellular parasites and toxoplasmacidal activity that was dependent on the autophagy protein ULK-1 and lysosomal enzymes. Conclusions: DN EGFR in the RPE increases resistance against ocular toxoplasmosis, an effect that would occur after retinal invasion by T. gondii. Protection is accompanied by autophagic killing of T. gondii in RPE. This report provides the first evidence that RPE can protect against ocular toxoplasmosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.